How we wrote a landmark nasopharyngeal intergroup phase III protocol in North America

被引:8
作者
Al-Sarraf, Muhyi [1 ,2 ]
机构
[1] William Beaumont Hosp, Royal Oak, MI 48072 USA
[2] Dept Med, Bloomfield, MI 48302 USA
关键词
D O I
10.1007/s13566-012-0022-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:95 / 98
页数:4
相关论文
共 15 条
[11]  
Giri PG, 2003, HEAD NECK EMERGING P, P491
[12]  
Giri PGS, 1996, 38 ANN ASTRO M 1002
[13]   Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma [J].
Ma, J ;
Mai, HQ ;
Hong, MH ;
Min, HQ ;
Mao, ZD ;
Cui, NJ ;
Lu, TX ;
Mo, HY .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (05) :1350-1357
[14]   Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation [J].
Rischin, D ;
Corry, J ;
Smith, J ;
Stewart, J ;
Hughes, P ;
Peters, L .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (07) :1845-1852
[15]   Epidemiology of nasopharyngeal carcinoma [J].
Yu, MC ;
Yuan, JM .
SEMINARS IN CANCER BIOLOGY, 2002, 12 (06) :421-429